tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market
IONS
Ionis Pharmaceuticals
RESEARCH TOOLSreports
Want to see IONS full AI Analyst Report?

Ionis Pharmaceuticals (IONS) Income Statement

1,498 Followers

Ionis Pharmaceuticals Income Statement

Last quarter (Q1 2026), Ionis Pharmaceuticals's total revenue was $246.09M, an increase of 86.98% from the same quarter last year. In Q1, Ionis Pharmaceuticals's net income was $-92.53M. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 944.00M$ 705.14M$ 787.65M$ 587.37M$ 810.46M
Gross Profit
$ 928.00M$ 693.92M$ 778.51M$ 573.25M$ 799.61M
Operating Expenses
$ 1.31B$ 1.17B$ 1.13B$ 983.44M$ 829.80M
Depreciation and Amortization
$ 20.25M$ 21.99M$ 22.50M$ 22.11M$ 19.56M
EBITDA
$ -286.75M$ -353.72M$ -235.87M$ -227.76M$ -5.19M
Operating Income
$ -382.00M$ -475.08M$ -353.73M$ -410.19M$ -30.19M
Other Income/Expenses
$ 2.00M$ 15.01M$ 19.77M$ 152.21M$ 1.04M
Pretax Income
$ -380.00M$ -460.07M$ -333.96M$ -257.99M$ -29.15M
Net Income
$ -381.00M$ -453.90M$ -366.29M$ -269.72M$ -28.60M
Per Share Metrics
Basic EPS
$ -2.38$ -3.04$ -2.56$ -1.90$ -0.20
Diluted EPS
$ -2.38$ -3.04$ -2.56$ -1.90$ -0.20
Weighted Average Shares Outstanding
 160.00M 149.51M 143.00M 141.85M 141.02M
Weighted Average Shares Outstanding (Diluted)
 160.00M 149.51M 143.19M 141.85M 141.02M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History